|
bivalirudin 250 mg (INJECTION)
|
$88.9270
|
|
VA FSS
|
|
| bivalirudin (10) |
Sandoz, Inc. |
|
|
bivalirudin 250 mg (INJECTION)
|
$313.1660
|
|
VA FSS
|
|
| Bivalirudin (10) |
Hospira Worldwide, LLC |
|
|
bivalirudin 250 mg (INJECTION)
|
$358.7940
|
|
VA FSS
|
|
| Bivalirudin (10) |
Fresenius Kabi, LLC |
|
|
bivalirudin 250 mg (INJECTION)
|
$395.8062
|
|
AUS PBS
|
generic
|
| Bivalirudin APOTEX (1) |
Apotex Pty Ltd |
| Angiomax (1) |
The Medicines Company (Australia) Pty Limited |
|
|
bivalirudin 250 mg (INJECTION)
|
$523.9580
|
|
VA FSS
|
|
| Angiomax (10) |
Sandoz, Inc. |
|
|
bivalirudin 250 mg / 50 mL (50 mL INJECTION)
|
$88.8008
|
|
VA FSS
|
|
| Bivalirudin in 0.9% Sodium Chloride (24) |
Baxter Healthcare Corporation |
|
|
bivalirudin 500 mg / 100 mL (100 mL INJECTION)
|
$210.7392
|
|
VA FSS
|
|
| Bivalirudin in 0.9% Sodium Chloride (12) |
Baxter Healthcare Corporation |
|
|
bivalirudin 5 mg / 1 mL (1 mL INJECTION)
|
$119.7210
|
|
VA FSS
|
|
| Bivalirudin (10) |
Athenex Pharmaceutical Division, LLC |
|
